• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Development of the first potential covalent inhibitors of anandamide cellular uptake.

作者信息

Schiano Moriello Aniello, Balas Laurence, Ligresti Alessia, Cascio Maria Grazia, Durand Thierry, Morera Enrico, Ortar Giorgio, Di Marzo Vincenzo

机构信息

Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, via dei Campi Flegrei 34, 80078 Pozzuoli (Napoli), Italy.

出版信息

J Med Chem. 2006 Apr 6;49(7):2320-32. doi: 10.1021/jm051226l.

DOI:10.1021/jm051226l
PMID:16570928
Abstract

On the basis of the chemical structures of two previously developed metabolically stable and relatively potent inhibitors of anandamide uptake, OMDM-1,2, two series of potential covalent inhibitors of anandamide cellular reuptake, which might be used for the molecular characterization of the protein(s) involved in the membrane transport of endocannabinoids, have been designed and synthesized. Most of the compounds inhibited uptake to a varied extent and in a generally enantio-sensitive manner when co-incubated with [(14)C]anandamide, but only three of them, the photoactivatable 1a (OMDM-37), 1b (OMDM-39), and 8(Lo395), also produced a significant inhibition of uptake following the preincubation only of the cells, and this effect was significantly enhanced following UV exposure only in the case of 8. None of the new compounds inhibited [(14)C]anandamide hydrolysis with IC(50) < 50 microM, except for 1b.

摘要

相似文献

1
Development of the first potential covalent inhibitors of anandamide cellular uptake.
J Med Chem. 2006 Apr 6;49(7):2320-32. doi: 10.1021/jm051226l.
2
Novel selective and metabolically stable inhibitors of anandamide cellular uptake.新型花生四烯乙醇胺细胞摄取的选择性及代谢稳定抑制剂。
Biochem Pharmacol. 2003 May 1;65(9):1473-81. doi: 10.1016/s0006-2952(03)00109-6.
3
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.与酶促水解相比,对花生四烯乙醇胺细胞摄取的选择性抑制——一个难以处理的问题。
Eur J Pharmacol. 2004 May 10;492(1):1-11. doi: 10.1016/j.ejphar.2004.03.048.
4
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.两种新型花生四烯酸乙醇胺细胞摄取抑制剂的体内药理作用。
Eur J Pharmacol. 2004 Jan 26;484(2-3):249-57. doi: 10.1016/j.ejphar.2003.11.027.
5
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.内源性大麻素摄取新抑制剂的设计、合成及生物学评价:与对脂肪酸酰胺水解酶的作用比较
J Med Chem. 2003 Apr 10;46(8):1512-22. doi: 10.1021/jm0210818.
6
Anandamide transport: a critical review.花生四烯乙醇胺转运:批判性综述。
Life Sci. 2005 Aug 19;77(14):1584-604. doi: 10.1016/j.lfs.2005.05.007.
7
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.不饱和长链N-酰基香草酰胺(N-AVAMs):抑制花生四烯乙醇胺促进转运并与CB1大麻素受体结合的香草酸受体配体。
Biochem Biophys Res Commun. 1999 Aug 19;262(1):275-84. doi: 10.1006/bbrc.1999.1105.
8
Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
Biochem Biophys Res Commun. 1997 Feb 3;231(1):82-8. doi: 10.1006/bbrc.1997.6000.
9
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.一系列单酰甘油水解抑制剂的构效关系——与对脂肪酸酰胺水解酶的作用比较
J Med Chem. 2007 Oct 4;50(20):5012-23. doi: 10.1021/jm070642y. Epub 2007 Sep 1.
10
The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.“特异性”酪氨酸激酶抑制剂染料木黄酮可抑制花生四烯酸乙醇胺的酶促水解:对花生四烯酸乙醇胺摄取的影响。
Br J Pharmacol. 2007 Apr;150(7):951-60. doi: 10.1038/sj.bjp.0707172. Epub 2007 Feb 26.

引用本文的文献

1
On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.内源性大麻素降解和再摄取抑制剂的生物医学特性:临床前和临床证据。
Neurotox Res. 2021 Dec;39(6):2072-2097. doi: 10.1007/s12640-021-00424-z. Epub 2021 Nov 6.
2
Selectively fluorinated cyclohexane building blocks: Derivatives of carbonylated all-cis-3-phenyl-1,2,4,5-tetrafluorocyclohexane.选择性氟化环己烷结构单元:羰基化全顺式-3-苯基-1,2,4,5-四氟环己烷的衍生物。
Beilstein J Org Chem. 2015 Dec 21;11:2671-6. doi: 10.3762/bjoc.11.287. eCollection 2015.
3
Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents.
用于旨在鉴定新型A组链球菌抗毒力剂靶点研究的无标签光探针的开发。
Bioorg Med Chem Lett. 2014 Mar 15;24(6):1538-44. doi: 10.1016/j.bmcl.2014.01.079. Epub 2014 Feb 7.
4
The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.“特异性”酪氨酸激酶抑制剂染料木黄酮可抑制花生四烯酸乙醇胺的酶促水解:对花生四烯酸乙醇胺摄取的影响。
Br J Pharmacol. 2007 Apr;150(7):951-60. doi: 10.1038/sj.bjp.0707172. Epub 2007 Feb 26.